Revenue
attach_money20M USD
YoY +31.6%
CARMCarisma Therapeutics, Inc.$ --
Carisma Therapeutics, Inc.
CARM
$ -
-
You can review earnings summary, quarterly trends, full-year progress, and detailed income statement data.
analyticsIncome Statement Summary
FY2024 Full YearUpdated: 12/31/2024
Operating Income
bar_chart-62M USD
YoY +29.9%
Net Income
verified-60M USD
YoY +30.4%
EPS
pie_chart-1.46USD
YoY +43.6%
Quarterly Performance
Quarterly revenue and net income trend
RevenueOperating IncomeNet Income
No quarterly data available
Full-Year Progress
Net Income Progress-88.4%Below Target
Revenue Progress49M
Revenue Forecast15M
Net Income Progress25.7M
Net Income Forecast-29M
Income Statement Details
Item
Revenue
Cost of revenue
Gross profit
Research & development
Selling & marketing
Selling, general and administrative
Other operating expenses
Operating income
Interest expense
Income before tax
Income tax expense
Net income
Unlock Long-Term Income Statement Data
Your current plan allows viewing financial data for the latest 1 year (annual only). Upgrade to the Standard Plan to view up to 3 years (including quarterly data), or the Premium Plan to access all historical data.